Det nye forumet finner du her

Tilbake til: Farma og medisin
Innlegg av: Simple (13.06.18 09:22 ), lest 377 ganger
Ticker: TRVX
Endret: 13.06.18 09:46

TRVX: Virker Oncos-102 + kjemoterapi? finnes bedre data

Jeg kan ikke mye biotec, kan noen kommentere dette? Er Oncos-102+kjemoterapi like dårlig som TG01+kjemoterapi?
Oncos-102 + Malignant Pleural Mesothelioma: ORR/partial responses(?):17% (1/6); SD:33% (2/6); DC (disease control):50%

June 04, 2016
Aduro Biotech Presents Encouraging Anti-Tumor Response Data From Ongoing Phase 1b Study in Malignant Pleural Mesothelioma at ASCO

Of the 36 evaluable patients, disease control was observed in 94% (34/36), including 3% (1/36) with a complete response, 56% (20/36) with partial responses and 36% (13/36) experiencing stable disease following treatment with CRS-207 and chemotherapy.

http://investors.aduro.com/phoenix.zhtml?c=242043&p=irol-newsArticle&ID=2175099

CRS-207 studien avsluttet, de skulle prioritere andre ting/kanskje pga bivirkning...! Håpet blir CPI+Oncos-102.